Bellerophon Therapeutics Earnings Calls

Q3 2024
Release date Dec 18, 2024
EPS estimate -$0.420
EPS actual -
Revenue estimate -
Revenue actual -
Q2 2024
Release date Sep 23, 2024
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -
Q1 2024
Release date Jun 06, 2024
EPS estimate -$0.420
EPS actual -
Revenue estimate -
Revenue actual -
Q4 2023
Release date Mar 01, 2024
EPS estimate -$0.330
EPS actual -
Revenue estimate -
Revenue actual -

Last 4 Quarters for Bellerophon Therapeutics

Below you can see how BLPH performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Q4 2023
Release date Mar 01, 2024
Fiscal end date Dec 30, 2023
Price on release $0.0516
EPS estimate -$0.330
EPS actual -
Date Price
Feb 26, 2024 $0.0533
Feb 27, 2024 $0.0523
Feb 28, 2024 $0.0533
Feb 29, 2024 $0.0515
Mar 01, 2024 $0.0516
Mar 04, 2024 $0.0515
Mar 05, 2024 $0.0527
Mar 06, 2024 $0.0527
Mar 07, 2024 $0.0550
4 days before -3.10%
4 days after 6.59%
On release day -0.194%
Change in period 3.29%
Q1 2024
Release date Jun 06, 2024
Fiscal end date Mar 30, 2024
Price on release $0.0575
EPS estimate -$0.420
EPS actual -
Date Price
May 31, 2024 $0.0600
Jun 03, 2024 $0.0560
Jun 04, 2024 $0.0565
Jun 05, 2024 $0.0562
Jun 06, 2024 $0.0575
Jun 07, 2024 $0.0575
Jun 10, 2024 $0.0600
Jun 11, 2024 $0.0650
Jun 12, 2024 $0.0620
4 days before -4.17%
4 days after 7.83%
On release day 0%
Change in period 3.33%
Q2 2024
Release date Sep 23, 2024
Fiscal end date Jun 30, 2024
Price on release $0.0350
EPS estimate -
EPS actual -
Date Price
Sep 17, 2024 $0.0350
Sep 18, 2024 $0.0350
Sep 19, 2024 $0.0350
Sep 20, 2024 $0.0350
Sep 23, 2024 $0.0350
Sep 24, 2024 $0.0350
Sep 25, 2024 $0.0350
Sep 26, 2024 $0.0350
Sep 27, 2024 $0.0350
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Q3 2024
Release date Dec 18, 2024
Fiscal end date Sep 30, 2024
Price on release $0.0120
EPS estimate -$0.420
EPS actual -
Date Price
Dec 12, 2024 $0.0121
Dec 13, 2024 $0.0190
Dec 16, 2024 $0.0190
Dec 17, 2024 $0.0190
Dec 18, 2024 $0.0120
Dec 19, 2024 $0.0120
Dec 20, 2024 $0.0120
Dec 23, 2024 $0.0120
Dec 24, 2024 $0.0120
4 days before -0.83%
4 days after 0%
On release day 0%
Change in period -0.83%

Bellerophon Therapeutics Earnings History

Earnings Calendar

FAQ

What is the BLPH price-to-earnings (P/E) ratio?
BLPH P/E ratio as of Feb 14, 2025 (TTM) is -0.0208.

What are Bellerophon Therapeutics's retained earnings?
On its balance sheet, Bellerophon Therapeutics reported retained earnings of $0 for the latest quarter ending Sep 30, 2024.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT BELLEROPHON THERAPEUTICS
Bellerophon Therapeutics
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w...
GOLDEN STAR
Ticker Change Signal Date
T
TBIL
$49.90
0.0802% Feb 12
I
IBTF
$23.33
0.0429% Feb 12
SKT
$33.58
2.00% Feb 12
BSY
$46.63
1.33% Feb 11
IBN
$29.02
0.482% Feb 11

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE